[{"address1": "Wagistrasse 14", "city": "Schlieren", "zip": "8952", "country": "Switzerland", "phone": "41 44 755 77 00", "fax": "41 44 755 77 07", "website": "https://www.molecularpartners.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Molecular Partners AG, a clinical-stage biotechnology company, designs and develops designed ankyrin repeat proteins therapeutics for the treatment of oncology diseases in Switzerland. Its product pipeline comprises MP0317, which is in Phase 1 clinical trial for the treatment of advanced solid tumors; MP053, novel tetra-specific T cell-engaging DARPin, which is phase 1 clinical trial for the treatment of acute myeloid leukemia; and MP0712, a 212Pb Radio-DARPin therapy (RDT) candidate targeting the tumor-associated protein delta-like ligand 3 (DLL3) which is in preclinical trial to treat SCLC and neuroendocrine tumors. It also researches for Switch-DARPin T cell engager to treat CD3 x costim x; and Radio-DARPin Therapy to treat ovarian disease. In addition, the company develops MP0621, a molecular partners' first Switch-DARPin program, which is in preclinical trial designed to induce killing of hematopoietic stem cells (HSCs) as a next-generation conditioning regimen for HSC transplantation (HSCT); and Radio-DARPin Therapy (RDT) platform, a delivery system for effective and selective delivery of radioactive payloads to solid tumors. It has collaboration agreement with Orano Med SAS to develop novel Radio-DARPin therapeutics and an additional six targeted alpha therapeutics candidates. Molecular Partners AG was incorporated in 2004 and is headquartered in Schlieren, Switzerland.", "fullTimeEmployees": 158, "companyOfficers": [{"maxAge": 1, "name": "Dr. Patrick  Amstutz Ph.D.", "age": 49, "title": "Co-Founder, CEO, Member of Management Board & Director", "yearBorn": 1975, "fiscalYear": 2024, "totalPay": 774843, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Michael Tobias Stumpp Ph.D.", "age": 52, "title": "Co-Founder, Executive VP of Projects & Member of Management Board", "yearBorn": 1972, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Robert  Hendriks", "title": "Senior VP of Finance", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Alexander  Zurcher", "age": 49, "title": "COO & Member of Management Board", "yearBorn": 1975, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Renate  Gloggner", "age": 54, "title": "Executive VP of People & Community and Member of Management Board", "yearBorn": 1970, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Philippe  Legenne M.B.A., M.D.", "age": 58, "title": "Chief Medical Officer & Member of the Management Board", "yearBorn": 1966, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Daniel  Steiner Ph.D.", "title": "Senior Vice President of Research & Technology", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Seth D. Lewis", "title": "Senior Vice President of Investor Relations, Communications & Strategy", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Michael  Pitzner", "title": "General Counsel, Compliance Officer, Senior VP Legal & Business Development", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Pamela A. Trail Ph.D.", "age": 68, "title": "Strategic Consultant", "yearBorn": 1956, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 3.6, "open": 3.595, "dayLow": 3.595, "dayHigh": 3.595, "regularMarketPreviousClose": 3.6, "regularMarketOpen": 3.595, "regularMarketDayLow": 3.595, "regularMarketDayHigh": 3.595, "payoutRatio": 0.0, "beta": 0.523, "forwardPE": -1.9538044, "volume": 407, "regularMarketVolume": 407, "averageVolume": 9772, "averageVolume10days": 1200, "averageDailyVolume10Day": 1200, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "marketCap": 132564192, "fiftyTwoWeekLow": 3.36, "fiftyTwoWeekHigh": 12.22, "priceToSalesTrailing12Months": 26.672876, "fiftyDayAverage": 3.78416, "twoHundredDayAverage": 4.66642, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -5072084, "profitMargins": 0.0, "floatShares": 14882000, "sharesOutstanding": 36874600, "sharesShort": 51170, "sharesShortPriorMonth": 39149, "sharesShortPreviousMonthDate": 1743379200, "dateShortInterest": 1745971200, "sharesPercentSharesOut": 0.0014, "heldPercentInsiders": 0.0, "heldPercentInstitutions": 0.09722, "shortRatio": 2.1, "shortPercentOfFloat": 0.0029, "impliedSharesOutstanding": 37251500, "bookValue": 3.841, "priceToBook": 0.93595415, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -54043000, "trailingEps": -2.12, "forwardEps": -1.84, "enterpriseToRevenue": -1.021, "enterpriseToEbitda": 0.084, "52WeekChange": -0.44263566, "SandP52WeekChange": 0.13161862, "quoteType": "EQUITY", "currentPrice": 3.595, "targetHighPrice": 17.266222, "targetLowPrice": 4.9708443, "targetMeanPrice": 10.924369, "targetMedianPrice": 10.730206, "recommendationMean": 1.5, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 4, "totalCash": 149439008, "totalCashPerShare": 4.054, "ebitda": -60229000, "totalDebt": 2444000, "quickRatio": 13.959, "currentRatio": 14.305, "totalRevenue": 4970000, "debtToEquity": 1.726, "revenuePerShare": 0.146, "returnOnAssets": -0.21441999, "returnOnEquity": -0.33982, "grossProfits": -42534000, "freeCashflow": -35437248, "operatingCashflow": -59248000, "revenueGrowth": -1.0, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": -12.3173, "financialCurrency": "CHF", "symbol": "MOLN", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1623850200000, "postMarketChangePercent": 1.5299045, "postMarketPrice": 3.65, "postMarketChange": 0.055000067, "regularMarketChange": -0.004999876, "regularMarketDayRange": "3.595 - 3.595", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 9772, "fiftyTwoWeekLowChange": 0.23500013, "fiftyTwoWeekLowChangePercent": 0.069940515, "fiftyTwoWeekRange": "3.36 - 12.22", "fiftyTwoWeekHighChange": -8.625, "fiftyTwoWeekHighChangePercent": -0.7058101, "fiftyTwoWeekChangePercent": -44.263565, "earningsTimestamp": 1756119540, "earningsTimestampStart": 1756119540, "earningsTimestampEnd": 1756119540, "earningsCallTimestampStart": 1741345140, "earningsCallTimestampEnd": 1741345140, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -2.12, "epsForward": -1.84, "epsCurrentYear": -1.77, "priceEpsCurrentYear": -2.0310736, "marketState": "CLOSED", "regularMarketChangePercent": -0.13888545, "regularMarketPrice": 3.595, "shortName": "Molecular Partners AG", "longName": "Molecular Partners AG", "corporateActions": [], "postMarketTime": 1752869046, "regularMarketTime": 1752868800, "exchange": "NMS", "messageBoardId": "finmb_32677064", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "fiftyDayAverageChange": -0.18915987, "fiftyDayAverageChangePercent": -0.049987283, "twoHundredDayAverageChange": -1.07142, "twoHundredDayAverageChangePercent": -0.22960213, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-06-16", "averageAnalystRating": "1.5 - Strong Buy", "cryptoTradeable": false, "trailingPegRatio": null, "__fetch_time": "2025-07-19"}]